Patents by Inventor Marshelle Smith WARREN

Marshelle Smith WARREN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DOSAGES FOR HDAC TREATMENT WITH REDUCED SIDE EFFECTS
    Publication number: 20240058347
    Abstract: Described herein are certain dosing schedules and amounts that effectively prevent and manage side effects associated with histone deacetylase inhibitor (HDACi) treatment. Optionally, these schedules and dosing regimens include treatment with an antiviral agent.
    Type: Application
    Filed: October 6, 2020
    Publication date: February 22, 2024
    Inventors: Robert MCRAE, Gail L. BROWN, David SLACK, Marshelle Smith WARREN, Richard TRAUGER
  • METHODS OF TREATING VIRALLY ASSOCIATED CANCERS WITH HISTONE DEACETYLASE INHIBITORS
    Publication number: 20220226322
    Abstract: Described herein are certain dosing schedules and amounts that effectively prevent and manage side effects associated with histone deacetylase inhibitor (HDACi) treatment. Optionally, these schedules and dosing regimens include treatment with an antiviral agent.
    Type: Application
    Filed: May 28, 2020
    Publication date: July 21, 2022
    Inventors: Robert MCRAE, Gail L. BROWN, Xiaohu DENG, David SLACK, Marshelle Smith WARREN, Richard TRAUGER
  • Methods of treating virally associated cancers with histone deacetylase inhibitors
    Patent number: 10953011
    Abstract: Described herein are certain dosing schedules and amounts that effectively prevent and manage side effects associated with histone deacetylase inhibitor (HDACi) treatment. Optionally, these schedules and dosing regimens include treatment with an antiviral agent.
    Type: Grant
    Filed: July 8, 2020
    Date of Patent: March 23, 2021
    Assignee: VIRACTA THERAPEUTICS INC.
    Inventors: Robert McRae, Gail L. Brown, Xiaohu Deng, David Slack, Marshelle Smith Warren, Richard Trauger
  • METHODS OF TREATING VIRALLY ASSOCIATED CANCERS WITH HISTONE DEACETYLASE INHIBITORS
    Publication number: 20200375990
    Abstract: Described herein are certain dosing schedules and amounts that effectively prevent and manage side effects associated with histone deacetylase inhibitor (HDACi) treatment. Optionally, these schedules and dosing regimens include treatment with an antiviral agent.
    Type: Application
    Filed: July 8, 2020
    Publication date: December 3, 2020
    Inventors: Robert MCRAE, Gail L. BROWN, Xiaohu DENG, David SLACK, Marshelle Smith WARREN, Richard TRAUGER